MICHAEL A HENNIGAN

Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism FAIRHOPE, AL NPI 1003971839

General Payments — all program years on this page

$27,266.78

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 322
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $401.39 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $401.3916

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $3,955.5450
2019 $6,722.9345
2020 $1,623.8181
2021 $8,308.2676
2022 $5,839.8532
2023 $415.0022
2024 $401.3916

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086957675 Novartis Pharmaceuticals Corporation $22.76 04/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086957701 Novartis Pharmaceuticals Corporation $30.61 10/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086957711 Novartis Pharmaceuticals Corporation $20.22 11/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086957717 Novartis Pharmaceuticals Corporation $24.02 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1093892909 Alexion Pharmaceuticals, Inc. $24.92 06/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097499153 Novo Nordisk Inc $62.48 05/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115715323 Amgen Inc. $21.56 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115715330 Amgen Inc. $16.18 07/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117765153 Corcept Therapeutics $19.07 08/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117834858 Boehringer Ingelheim Pharmaceuticals, Inc. $13.32 12/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117834860 Boehringer Ingelheim Pharmaceuticals, Inc. $20.06 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135209601 Lilly USA, LLC $20.59 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135209605 Lilly USA, LLC $21.99 05/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135218664 Lilly USA, LLC $18.16 05/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146463108 Antares Pharma, Inc. $28.61 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153322168 Dexcom, Inc. $36.84 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.